SCHEDULE 13G/A: Samjo Management and Andrew N. Wiener Disclose Negligible Passive Stake in OptimizeRx Corporation

An amended Schedule 13G filing reveals that Samjo Management, LLC and Andrew N. Wiener beneficially own a combined 50 shares, representing 0.0% of OptimizeRx Corporation's common stock, indicating a passive and non-influential holding.

Summary

• Samjo Management, LLC and Andrew N. Wiener have filed an Amendment No. 1 to their Schedule 13G regarding OptimizeRx Corporation's Common Stock.
• As of December 31, 2024, both Samjo Management, LLC and Andrew N. Wiener each beneficially own 50 shares of OptimizeRx Corporation's common stock.
• This aggregate beneficial ownership represents 0.0% of the total class of securities for both reporting persons.
• The filing indicates that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Samjo Management, LLC is classified as an Investment Adviser (IA) and Other (OO), while Andrew N. Wiener is classified as a Parent Holding Company (HC) and Individual (IN).
• All reported securities are directly owned by advisory clients of Samjo Management, LLC, with no single client beneficially owning more than 5% of the Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing a negligible, passive ownership stake. It contains no financial performance data, strategic updates, or significant changes that would warrant a positive or negative sentiment. It is purely informational regarding a very minor holding.

Positives

• The filing confirms that the reporting persons' holdings are passive and not intended to influence or change control of OptimizeRx Corporation, which can be seen as a stable, non-activist position.

Negatives

• The beneficial ownership of 0.0% of the class of securities by these reporting persons is negligible, indicating a lack of significant institutional investment or strategic interest from these specific entities.
• The extremely low percentage suggests these filers hold no material influence over the company's operations or strategic direction.

Risks

• The minimal ownership by these reporting persons means they are unlikely to provide any significant oversight, strategic input, or capital support to OptimizeRx Corporation.
• A lack of substantial institutional ownership by entities like Samjo Management, LLC could be perceived as a lack of strong institutional conviction in the company's long-term prospects by some investors, though this filing alone is not conclusive.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
• "Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."

Industry Context

This Schedule 13G/A filing is a routine disclosure required by the SEC when an entity or individual acquires beneficial ownership of more than 5% of a company's voting class of securities, or amends a previous filing. In this case, it's an amendment indicating a very small, passive holding (0.0%) by an investment adviser and an individual, which is common for institutional investors who do not seek to influence management or control the company.

Comparison to Industry Standards

• The 0.0% beneficial ownership reported by Samjo Management, LLC and Andrew N. Wiener is exceptionally low and falls significantly below typical institutional investment thresholds, which often range from 1% to over 10% for active or even passive funds.
• Unlike major institutional investors such as BlackRock or Vanguard, who often hold substantial passive stakes (e.g., 5-15%) across numerous companies like Apple or Microsoft for index tracking, the reported holding here is negligible and does not represent a material investment or strategic position.
• This level of ownership is not comparable to significant activist stakes (e.g., Carl Icahn's past 10%+ stake in Herbalife) or even substantial passive holdings that might still confer some influence through voting power.

Stakeholder Impact

• Shareholders: Minimal to no direct impact, as the reported ownership is negligible and does not suggest any change in control or strategic direction.
• Employees, Customers, Suppliers, Creditors: No discernible impact, as the filing pertains solely to a passive, non-influential ownership disclosure.

Key Dates

Keywords

OptimizeRx Corporation, Schedule 13G/A, Beneficial Ownership, SEC Filing, Common Stock, Samjo Management, Andrew N. Wiener, Passive Investment, Institutional Ownership, Healthcare Technology